Home › Clinical Tools
Clinical Calculators & Medical Scores
Guideline-based bedside calculators for clinicians. Free, mobile-friendly, computed locally — no data uploaded.
Anesthesiology
Cardiology
🩸 MAP
Estimate mean arterial pressure from systolic and diastolic blood pressure.
📈 QTc
Heart-rate–corrected QT interval.
🩸 HAS-BLED
Major-bleeding risk on anticoagulation in atrial fibrillation.
❤️ HEART
Risk of major adverse cardiac events in ED chest pain.
🧈 LDL
Calculate LDL cholesterol from a lipid panel (Friedewald).
🫀 CHA₂DS₂-VASc
Annual stroke risk in non-valvular atrial fibrillation.
🫀 RCRI
Peri-operative major cardiac risk in noncardiac surgery.
❤️ TIMI
14-day risk of death, MI or urgent revascularisation in UA/NSTEMI.
❤️ Sgarbossa
Detect acute MI in the presence of LBBB or ventricular pacing.
❤️ RPP
Estimate myocardial oxygen demand (HR × systolic BP).
❤️ Pulse pressure
Difference between systolic and diastolic pressure.
🫀 Castelli
Atherogenic cholesterol ratios (I: TC/HDL, II: LDL/HDL).
🩸 TG/HDL
Surrogate for insulin resistance and atherogenic dyslipidaemia.
🫀 LDL (calc)
Calculate LDL cholesterol from a standard lipid panel.
🫀 NYHA
Symptomatic functional classification of heart failure.
❤️ Killip
Heart-failure severity and prognosis in acute myocardial infarction.
💓 LVH index
ECG voltage criteria for left ventricular hypertrophy.
💓 Duke TMS
Prognostic score from exercise ECG (Bruce protocol).
🩸 ORBIT
Estimate major bleeding risk on anticoagulation in atrial fibrillation.
🩸 ATRIA
Predict major haemorrhage risk on warfarin in atrial fibrillation.
❤️ HEART
Risk-stratify chest pain in the emergency department for major adverse cardiac events.
❤️ H2FPEF
Estimate the probability of heart failure with preserved ejection fraction.
❤️ TIMI STEMI
Predict 30-day mortality in ST-elevation myocardial infarction.
💊 DAPT
Weigh benefit vs bleeding risk of prolonged dual antiplatelet therapy after PCI.
❤️ Marburg
Estimate likelihood that chest pain is due to coronary artery disease in primary care.
❤️ EDACS
Risk-stratify possible cardiac chest pain (Emergency Department Assessment of Chest Pain Score).
Critical care
⚠️ qSOFA
Quick SOFA for risk of poor outcome in suspected infection.
⚠️ NEWS2
Aggregate early-warning score for acute deterioration (SpO2 scale 1).
🌡️ SIRS
Systemic inflammatory response syndrome criteria (≥ 2 positive).
🫀 SOFA
Grade organ dysfunction in critically ill patients (6 systems, 0–4 each).
🫁 OI
Oxygenation severity in ventilated patients (esp. paediatric ARDS).
🫁 ROX
Predict success of high-flow nasal cannula in acute hypoxaemic respiratory failure.
🧠 FOUR
Full Outline of UnResponsiveness — coma scale usable in intubated patients.
🛏️ RASS
Grade agitation and sedation depth in the ICU.
🚨 MEWS
Bedside physiological score to detect clinical deterioration.
🩸 CaO₂
Total oxygen carried per 100 mL of arterial blood.
🫀 DO₂
Rate of oxygen delivery to tissues.
🫀 SVR
Afterload estimate from haemodynamic measurements.
🔪 Surgical Apgar
Predict major postoperative complications and death from intraoperative data.
🤢 Apfel PONV
Predict postoperative nausea and vomiting risk.
🫁 CPIS
Support diagnosis of ventilator-associated pneumonia.
🫁 HACOR
Predict non-invasive ventilation failure in hypoxaemic respiratory failure.
🧪 Compensation
Given a primary acid-base disorder, computes the expected compensation; deviation suggests a second disorder.
🧂 Corrected Na
Hyperglycemia dilutionally lowers measured sodium; correct sodium for glucose (Katz and Hillier).
🫁 RSBI
RSBI = respiratory rate ÷ tidal volume (L); < 105 predicts successful weaning/extubation (Yang-Tobin).
🫁 ARISCAT
Seven items estimating the risk of postoperative pulmonary complications in non-cardiac surgery (low/intermediate/high).
Emergency
🔥 Parkland
24-hour crystalloid resuscitation volume for major burns.
🩹 Alvarado
Likelihood of acute appendicitis (MANTRELS).
📉 Shock Index
Heart rate divided by systolic BP — a marker of haemodynamic instability.
🦶 Ottawa Ankle
Decide whether ankle/foot X-rays are needed after injury.
🦵 Ottawa Knee
Decide whether a knee X-ray is needed after acute injury.
🧠 CCHR
Whether CT is needed after minor head injury (GCS 13–15).
🦴 NEXUS
Determine whether cervical-spine imaging can be safely deferred after trauma.
🦴 Canadian C-spine
Stepwise rule for cervical-spine imaging in alert, stable trauma patients.
🧠 ROSIER
Recognition of stroke in the emergency room.
🫀 SF Syncope
Identify syncope patients at risk of a serious 7-day outcome (CHESS).
🦠 LRINEC
Lab-based risk indicator for necrotising soft-tissue infection.
🦠 McIsaac
Estimate likelihood of group A streptococcal pharyngitis.
🫀 ADD-RS
Screen for acute aortic syndrome across three feature categories.
🪨 STONE
Predict the likelihood of an uncomplicated ureteral stone in acute flank pain.
🚑 RTS
Physiologic trauma severity score for triage and outcome prediction.
🩸 ABC
Predict need for massive transfusion in trauma.
🫀 CSRS
Predict 30-day serious adverse events after emergency department syncope.
🔥 Revised Baux
Estimate mortality risk after major burns.
🩸 TASH
Seven weighted parameters (sex/SBP/HR/Hb/base excess/FAST/complex fracture) predicting the probability of massive transfusion in severe trauma (0–28).
🔥 Rule of Nines
Estimate adult burn total body surface area (% TBSA, Wallace rule of nines) for resuscitation and referral decisions.
🩸 ATLS shock
Classify ATLS hemorrhagic shock (I–IV) from vital signs and mental status/urine output, with resuscitation direction.
🦠 MPI
Eight perioperative parameters predicting mortality in secondary peritonitis (Mannheim Peritonitis Index).
🔥 ABSI
Estimate burn severity and survival probability from sex, age, inhalation injury, full-thickness burn and %TBSA.
Endocrinology
Gastroenterology
🩸 GBS
Risk of needing intervention in upper GI bleeding; identifies low-risk patients.
🩸 Rockall
Rebleeding and mortality risk after upper GI bleeding (complete score).
🫃 Ranson
Severity and mortality risk in acute pancreatitis (non-gallstone).
🫃 BISAP
Early mortality risk in acute pancreatitis (within 24 h).
🫃 Imrie
Severity of acute pancreatitis (PANCREAS criteria, at 48 h).
🩸 Forrest
Endoscopic stigmata of peptic ulcer bleeding and rebleed risk.
🚽 Wexner
Cleveland Clinic faecal incontinence severity score.
💩 Bristol
Classify stool form as a marker of transit time.
🩸 AIMS65
Predict in-hospital mortality in acute upper gastrointestinal bleeding.
🔪 Boey
Predict mortality and morbidity in perforated peptic ulcer.
🩸 GBS
Upper GI bleed risk score predicting need for intervention (transfusion, endoscopy, surgery).
🩻 CTSI
Compute the acute pancreatitis CT severity index from the Balthazar CT grade and extent of necrosis (0–10).
General
⚖️ BMI
Calculate body mass index from weight and height, with WHO weight-status category.
📐 BSA
Estimate body surface area (Mosteller formula) for dosing.
⚖️ IBW
Ideal body weight and adjusted body weight for dosing.
📏 WHR
Central adiposity and cardiometabolic risk indicator.
🩸 TyG
Surrogate marker of insulin resistance.
📋 Charlson
Comorbidity burden and 10-year survival estimate.
🩸 FINDRISC
10-year risk of developing type 2 diabetes.
🧪 HOMA-β
Estimate pancreatic beta-cell function from fasting glucose and insulin.
🧪 QUICKI
Quantitative insulin-sensitivity check index.
Hematology
🦵 Wells DVT
Pre-test probability of deep vein thrombosis.
🫁 Wells PE
Pre-test probability of pulmonary embolism.
🫁 PERC
Rule out PE in low-risk patients without D-dimer (all 8 negative).
🦵 Padua
VTE risk in hospitalised medical patients.
🩸 Mentzer
Differentiate iron deficiency from thalassaemia trait in microcytosis.
🦠 ANC
Calculate ANC to grade neutropenia and infection risk.
🫁 Geneva
Clinical pre-test probability of pulmonary embolism (objective, revised Geneva).
🦵 IMPROVE VTE
VTE risk in hospitalised medical patients (IMPROVE model).
🫁 sPESI
Risk-stratify acute PE for 30-day mortality (simplified PESI).
🫁 PESI
30-day mortality class in acute PE (original PESI).
🩸 Iron deficit
Calculate total iron deficit for replacement.
🩸 TSAT
Assess iron status from serum iron and TIBC.
🩸 4Ts
Pre-test probability of HIT.
🦠 NLR
An inflammatory and prognostic marker from the differential.
🦠 SII
Composite inflammatory marker (platelet × neutrophil / lymphocyte).
🩸 RPI
Assess the marrow response to anaemia (corrected reticulocyte count).
🩸 4Ts
Pre-test probability of heparin-induced thrombocytopenia (HIT).
🩸 ISTH DIC
Diagnose overt disseminated intravascular coagulation.
🩸 PLASMIC
Probability of severe ADAMTS13 deficiency (TTP) in thrombotic microangiopathy.
🫁 BOVA
Stratify 30-day risk in normotensive (non-high-risk) pulmonary embolism.
🏠 Hestia
Decide eligibility for outpatient management of pulmonary embolism.
🦵 Caprini
Venous thromboembolism risk stratification for surgical inpatients (2005 version) to guide prophylaxis.
Hepatology
🫀 Child-Pugh
Grade severity of chronic liver disease (Class A/B/C).
🫀 MELD-Na
Model for End-stage Liver Disease with sodium (UNOS).
🧫 FIB-4
Non-invasive estimate of advanced hepatic fibrosis.
🫀 Maddrey DF
Severity of alcoholic hepatitis and steroid decision threshold.
🫀 GAHS
Prognosis in alcoholic hepatitis to guide corticosteroid use.
🫀 APRI
Non-invasive marker of hepatic fibrosis/cirrhosis.
🫀 NFS
Predict advanced fibrosis in non-alcoholic fatty liver disease.
🫃 SAAG
Determine whether ascites is due to portal hypertension.
🫀 West Haven
Grade the severity of hepatic encephalopathy.
🫀 Lille
Predict response to corticosteroids at day 7 of treatment.
📊 MELD 3.0
Latest MELD for end-stage liver disease, adding sex, albumin and interaction terms.
🫀 Milan
Determine whether hepatocellular carcinoma meets the Milan criteria — the classic morphologic standard for liver transplant candidacy.
Infectious disease
Nephrology
🧪 Anion Gap
Serum anion gap with optional albumin correction.
🫘 CrCl
Estimate creatinine clearance for renal drug dosing.
🫘 eGFR
Estimated GFR by the race-free CKD-EPI 2021 creatinine equation.
🫘 FENa
Differentiate pre-renal from intrinsic acute kidney injury.
🫁 Winter's
Expected PaCO₂ for a metabolic acidosis.
🧪 Serum Osm
Calculated serum osmolality and reference for osmolal gap.
🫘 TTKG
Assess renal potassium handling in dyskalaemia.
🧪 Delta ratio
Detect a mixed metabolic acid–base disorder.
💧 Water deficit
Estimate the free water deficit in hypernatraemia.
🫘 Urine AG
Assess urinary ammonium in normal-anion-gap metabolic acidosis.
🧪 Corrected Na
Adjust measured sodium for the dilutional effect of high glucose.
🧪 Na deficit
Estimate the sodium deficit to plan correction in hyponatraemia.
🫘 FEUrea
Differentiate pre-renal AKI from ATN, useful after diuretics.
🦴 Corrected Ca
Adjust total calcium for low albumin.
🧪 Corrected AG
Adjust the anion gap for hypoalbuminaemia.
🧪 HCO₃ deficit
Estimate the bicarbonate deficit in metabolic acidosis.
🦴 Ca × PO₄
Product of calcium and phosphate, relevant to vascular calcification risk.
🧫 Mehran
Predict contrast-induced acute kidney injury risk after PCI.
Neurology
🧠 GCS
Score consciousness from eye, verbal and motor responses (3–15).
🧠 ABCD²
Short-term stroke risk after a transient ischaemic attack.
🧠 NIHSS
Quantify neurological deficit severity in acute stroke (0–42).
🧠 mRS
Global disability/dependence after stroke.
🧠 Mini-Cog
Brief screen for cognitive impairment.
🧠 ICH Score
30-day mortality risk after intracerebral haemorrhage.
🧠 Hunt-Hess
Clinical severity grading of aneurysmal SAH.
🧠 WFNS
GCS-based grading of aneurysmal SAH.
🧠 Mod. Fisher
CT-based vasospasm risk after subarachnoid haemorrhage.
🧠 LAMS
Pre-hospital screen for large-vessel occlusion.
🧠 FAST-ED
Field assessment for large-vessel occlusion stroke.
🧠 GCS-P
Combine Glasgow Coma Scale with pupil reactivity for finer prognostication.
🩻 Carotid stenosis
Compute extracranial ICA stenosis from diameters (NASCET, optional ECST) with grade and management direction.
🩻 Intracranial stenosis
Compute intracranial arterial stenosis from diameters (WASID method) with grade and management direction (distinct from extracranial NASCET).
🧠 PHASES
Estimates the 5-year rupture risk of an unruptured intracranial aneurysm from population, hypertension, age, size, prior SAH and site.
🧠 ELAPSS
Estimates the 3/5-year growth risk of an unruptured intracranial aneurysm from prior SAH, location, age, population, size and shape.
🧠 S-M AVM
Surgical risk grade for brain arteriovenous malformation, summing size, eloquence and venous drainage (grade 1–5).
Obstetrics
Oncology
🚶 ECOG PS
Functional status grading used in oncology.
🚶 Karnofsky
Functional status on a 0–100 scale.
🧬 Khorana
Predict venous thromboembolism risk in ambulatory cancer patients on chemotherapy.
🦠 MASCC
Identify low-risk febrile neutropenia suitable for outpatient management.
🧬 IPI
Prognosis in aggressive non-Hodgkin lymphoma.
🧬 FLIPI
Prognosis in follicular lymphoma.
🧬 mGPS
Inflammation-based prognostic score in cancer.
🧬 PNI
Nutrition/immune index predicting surgical and oncologic outcomes.
🎗️ RMI
RMI = ultrasound score U × menopausal status M × CA-125; a cut-off of 200 separates benign from malignant and guides gynecologic-oncology referral.
🎗️ GTN score
Sum of 8 prognostic factors for gestational trophoblastic neoplasia; ≤ 6 low risk (single-agent chemo), ≥ 7 high risk (combination chemo).
Pediatrics
👶 APGAR
Rapid assessment of newborn condition at 1 and 5 minutes.
💧 Maint. fluids
Daily and hourly maintenance fluid requirements by weight.
🫘 Schwartz eGFR
Bedside paediatric estimated GFR from height and creatinine.
👶 Corrected age
Adjust chronological age for prematurity.
🦴 Kocher
Differentiate septic arthritis from transient synovitis in a child's hip.
👶 Westley Croup
Grade croup severity in children.
👶 PAS
Assess likelihood of appendicitis in children.
👶 Silverman
Grade respiratory distress in the newborn (0 = no distress).
👶 Downes
Assess neonatal respiratory distress severity.
👶 NIPS
Assess procedural pain in neonates and young infants.
🧒 PECARN
Decision rule for head CT in minor head trauma (GCS 14–15) in children ≤ 18 y, with separate < 2 y and ≥ 2 y pathways.
🧒 PEWS
Brighton PEWS: behaviour/cardiovascular/respiratory each 0–3 (+ continuous nebs and post-op vomiting +2 each) to detect clinical deterioration in children.
🧒 Pediatric GCS
Modified infant/child GCS: eye (4) + verbal (5) + motor (6), total 3–15, to assess level of consciousness.
🧒 PRAM
Five signs (suprasternal retraction, scalene contraction, air entry, wheezing, oxygen saturation) totaling 0–12 to grade pediatric acute asthma severity.
🧒 Pediatric ETT
Estimate pediatric endotracheal tube internal diameter (uncuffed/cuffed) and insertion depth by age (~ 1–10 y; infants by weight).
👶 Ballard
Estimate neonatal gestational age from neuromuscular and physical maturity subtotals (GA = 24 + 0.4 × total).
🚨 Peds code card
Weight-based PALS emergency drugs and electrical therapy doses (epinephrine/amiodarone/adenosine/atropine/defibrillation/fluids, etc.).
Pharmacology
💊 Corr. phenytoin
Adjust total phenytoin level for low albumin (Sheiner-Tozer).
⚖️ AdjBW
Adjusted body weight for drug dosing in obesity.
💪 LBM
Estimate lean body mass for dosing and physiology.
💊 Opioid equiv
Convert daily opioid doses between agents via oral morphine equivalents (OME), with an incomplete cross-tolerance reduction range.
💊 Benzo equiv
Convert between benzodiazepines by diazepam equivalents, for switching and tapering (long-acting substitution for short-acting agents).
💉 Vancomycin
Empiric vancomycin loading dose, maintenance dose and interval by weight and creatinine clearance (AUC-guided; requires TDM).
💊 APAP safety
Check acetaminophen daily/single-dose limits and whether an acute ingestion reaches the toxic threshold or warrants NAC.
💉 Aminoglycoside
Gentamicin/tobramycin/amikacin high-dose extended-interval (once-daily) empiric dosing by dosing weight and CrCl; requires TDM.
🫘 Renal adjust
Quick reference for adjusting common renally-cleared drugs by renal function (CrCl/eGFR); not exhaustive — follow the latest product label.
📈 QTc risk
Quick reference to high-risk drug classes, risk factors and management for QT prolongation / torsades (TdP); per-drug authoritative ratings at CredibleMeds.
🤰 Pregnancy meds
The former FDA letter categories (withdrawn 2015), the PLLR labelling rule, prescribing principles and authoritative resources; not a per-drug rating.
🎯 TDM targets
Quick reference to target ranges, sampling timing and toxicity cues for commonly monitored drugs.
🫀 Hepatic adjust
Adjustment and avoidance points for common drugs in hepatic impairment (Child-Pugh), by class; follow the product label.
🔗 DDI key points
Quick reference to mechanisms and typical combinations for high-frequency, dangerous drug interactions; check each pair in a professional interaction database.
🩸 Warfarin INR
Target INR, high-INR/bleeding management (ACCP/CHEST), interactions and missed-dose points.
Psychiatry
🧠 GAD-7
Screen and grade generalised anxiety severity.
🍷 CAGE
Brief screen for problem drinking.
🍺 AUDIT-C
Three-item screen for hazardous drinking.
🧠 CAM
Bedside screen for delirium.
🍷 CIWA-Ar
Grade alcohol withdrawal severity to guide symptom-triggered treatment.
💊 COWS
Grade opioid withdrawal severity (Clinical Opiate Withdrawal Scale).
🧠 PHQ-2
Two-item screen for depression over the last 2 weeks.
Respiratory
🫁 CURB-65
Community-acquired pneumonia severity and disposition.
🫁 A–a gradient
Alveolar–arterial oxygen gradient (room air, sea level by default).
🚬 Pack-years
Cumulative cigarette exposure for screening and risk.
🫁 P/F ratio
Oxygenation index for ARDS severity (Berlin definition).
😴 Epworth
Quantify daytime sleepiness across eight everyday situations.
😴 STOP-BANG
Screen for obstructive sleep apnoea risk.
🫁 Light's
Classify a pleural effusion as exudate or transudate.
🫁 BODE
Multidimensional prognosis in COPD.
🫁 DECAF
In-hospital mortality risk in acute COPD exacerbation.
🫁 SMART-COP
Predict need for intensive respiratory or vasopressor support in CAP.
🫁 mMRC
Grade breathlessness in chronic respiratory disease.
🫁 CRB-65
Pneumonia severity without laboratory tests (community setting).
🫁 CAT
Health-status impact of COPD across 8 items.
🫁 ACT
Assess asthma control over the past 4 weeks.